Table 1.
Baseline demographic and clinical characteristics of patients.
| N | % | |
|---|---|---|
| Age, mean ± SD | ||
| 54,75, ± 10,4 | ||
| Sex (nb, %) | ||
| Male | 15 | 21,43 |
| Female | 55 | 78.57 |
| Current marital status (nb, %) | ||
| Married | 41 | 58.57 |
| Single | 15 | 21.43 |
| Divorced | 11 | 15.71 |
| Widowed | 2 | 2.86 |
| Cohabiting | 1 | 1.43 |
| Total | 70 | 100.00 |
| Current employment status (nb, %) | ||
| Pensioner | 23 | 33.82 |
| Unemployed | 20 | 29.41 |
| Employee | 19 | 27.94 |
| Executive or liberal profession | 5 | 7.35 |
| Worker | 1 | 1.47 |
| Total | 68 | 100.00 |
| Benzodiazepine intake at baseline: number of different benzodiazepine molecules (no, %) | ||
| 1 | 29 | 41.43 |
| 2 | 26 | 37.14 |
| 3 | 13 | 18.57 |
| 5 | 1 | 1.43 |
| 6 | 1 | 1.43 |
| Benzodiazepine equivalent dose (diazepam), mean ± SD | ||
| 15.3 mg ± 12.4 | ||
| Duration of benzodiazepine use before inclusion (nb, %) | ||
| ≥3 years | 53 | 80.30 |
| ≥1 years | 6 | 9.09 |
| ≥6 months | 5 | 7.58 |
| between 3 and 6 months | 2 | 3.03 |